industries

Orexigen Shares Jump Ahead Of FDA Decision

Published January 31, 2011

MarketWatch Pulse

BOSTON -- Shares of Orexigen Therapeutics jumped 10% Monday morning. The U.S. Food and Drug Administration is expected to issue a decision by the end of Monday on whether it will approve Orexigen's diet drug Contrave.

View Article

View Article

Follow Fox Business

Sections

Browse

Shows

About

Follow

Quotes delayed at least 15 minutes. Real-time quotes provided by BATS Exchange. Market Data provided by Interactive Data (Terms & Conditions). Powered and Implemented by Interactive Data Managed Solutions. Company fundamental data provided by Morningstar. Earnings estimates data provided by Zacks. Mutual fund data provided by Lipper. Economic data provided by Econoday. Dow Jones & Company Terms & Conditions.

This material may not be published, broadcast, rewritten, or redistributed. © 2012 FOX News Network, LLC. All rights reserved.